Make us your home page
Instagram

Today’s top headlines delivered to you daily.

(View our Privacy Policy)

Are statins wonder drugs, or just false hopes?

These and other brands of statins are prescribed to help lower cholesterol.

Times file photo

These and other brands of statins are prescribed to help lower cholesterol.

About 24 million Americans take statin drugs — including Pravachol, Mevacor, Lipitor, Zocor and Crestor — largely to stave off heart attacks and strokes.

But in recent months the drugs have come under tough scrutiny.

Statins were initially approved by the Food and Drug Administration for preventing repeat heart attacks and strokes in patients with high cholesterol. Used for that "secondary prevention" purpose, the drugs drive down the risk of another heart attack or stroke by lowering levels of LDL (or "bad") cholesterol.

Then physicians came to believe statins could also reduce the risk of a first heart attack in those with factors such as high LDL cholesterol or diabetes. Today, most people who use statins do so for such "primary prevention'' of heart attacks and strokes, a use that has become controversial.

"There's a conspiracy of false hope," says Harvard Medical School's Dr. John Abramson, who has co-written several critiques of the rise in statin use, including one published in June in the Archives of Internal Medicine. "The public wants an easy way to prevent heart disease, doctors want to reduce their patients' risk of heart disease and drug companies want to maximize the number of people taking their pills to boost their sales and profits."

The FDA assesses drugs' safety and effectiveness for specific use; but its judgments are based on preliminary data, most of it generated by a drug company seeking approval for its product.

Sometimes, by the time medical research and debate suggest a drug may not be all it's been cracked up to be, it's already become a bestseller. Statins, say some who study the relationship between medicine and the drug industry, seem to fit that pattern.

Statins appear to drive down the risk of heart attack or stroke by lowering the levels of fatty deposits circulating in the bloodstream. Research suggests that the drugs dampen inflammatory processes that can prompt deposits of plaque to break away from blood vessel walls and cause sudden blockages of arteries leading to the heart or brain.

And yet, the relationship between cholesterol-lowering and heart disease is not perfectly understood, and the precise role of inflammation in heart disease is also uncertain.

Statins certainly decrease rates of heart attack in people who have clear signs of cardiovascular disease.

The issue in the latest round of debate is whether statins prevent, safely and at a reasonable cost, cardiovascular disease in people considered to be at high risk of a first heart attack or stroke.

In the first of three studies published recently in the Archives of Internal Medicine, medical researchers found that, contrary to widely held belief, statins do not drive down death rates among those who take them to prevent a first heart attack. A second article cast significant doubt on the influential findings of a 2006 study, called JUPITER, that has driven the expansion of statins' use by healthy people with elevated blood levels of C-reactive protein, a measure of inflammation. A third article suggested potential ethical, clinical and financial conflicts of interest at work in the execution of the JUPITER study.

Statins still have ardent admirers, including cardiologist Steven Nissen of the Cleveland Clinic, who notes that even if statins do not reduce heart attack deaths, lives are improved by pushing a heart attack further into the future.

Harvard's Abramson, author of Overdosed America, said the best way to drive down the risk is not pills, but healthy diet, exercise, no smoking and moderate drinking.

Are statins wonder drugs, or just false hopes? 08/11/10 [Last modified: Wednesday, August 11, 2010 6:05pm]
Photo reprints | Article reprints

Copyright: For copyright information, please check with the distributor of this item, Los Angeles Times.
    

Join the discussion: Click to view comments, add yours

Loading...
  1. Florida education news: Irma makeup days, HB 7069, charter schools and more

    Blogs

    MAKEUP DAYS: Florida education commissioner Pam Stewart waives two of the required 180 days of instruction to help districts complete the …

    Education Commissioner Pam Stewart
  2. Rays morning after: At least Archer looked good

    Blogs

     

  3. Financially strapped Brooksville raises tax rate and fire fees

    Local Government

    BROOKSVILLE — After conducting an intensive examination of the city's financial position over the past couple of months, the Brooksville City Council has settled on its 2017-18 budget and a tax increase and fire fee increase to help pay for it.

    City Council member Joe Bernardini voted against the budget and the tax rate increase, saying it contained no employee raises and almost no capital expenses.
  4. Mexicans dig through collapsed buildings as quake kills at least 217 (w/video)

    World

    MEXICO CITY — Police, firefighters and ordinary Mexicans dug frantically through the rubble of collapsed schools, homes and apartment buildings early Wednesday, looking for survivors of Mexico's deadliest earthquake in decades as the number of confirmed fatalities stood at 217.

    A man is rescued from a collapsed building in the Condesa neighborhood after an earthquake struck Mexico City, Tuesday, Sept. 19, 2017. The 7.1 earthquake stunned central Mexico, killing more than 100 people. [Associated Press]
  5. Lacking support, lobbying ordinance gets no hearing in Hernando

    Local Government

    BROOKSVILLE — A push to publicly identify people who lobby top county officials was rejected by a majority of the Hernando County Commission this week when commissioners decided to pull a proposed lobbying ordinance from the agenda.

    Commissioner Steve Champion said there was not a consensus to bring a lobbying ordinance forward so the item should not have been placed on the agenda.